Shanghai Pharmaceuticals
(OTC) SHPMY
Shanghai Pharmaceuticals Financials at a Glance
Market Cap
$1.35B
Revenue (TTM)
CN¥287.69B
Net Income (TTM)
CN¥5.81B
EPS (TTM)
$1.10
P/E Ratio
6.68
Dividend
$0.29
Beta (Volatility)
0.15 (Low)
Dividend
$0.29
Beta (Volatility)
0.15 (Low)
Price
$7.34
Volume
1
Open
$7.34
Price
$7.34
Volume
1
Open
$7.34
Previous Close
$7.34
Daily Range
$7.34 - $7.34
52-Week Range
$6.83 - $8.32
Estimated Earnings Date
Apr 27, 2026
Dividend
$0.29
Beta (Volatility)
0.15 (Low)
Price
$7.34
Volume
1
Open
$7.34
Previous Close
$7.34
Daily Range
$7.34 - $7.34
52-Week Range
$6.83 - $8.32
Estimated Earnings Date
Apr 27, 2026
SHPMY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Shanghai Pharmaceuticals
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
49,608
CEO
Da Wei Liu
Website
www.sphchina.comHeadquarters
Shanghai, 200020, CN
SHPMY Financials
Key Financial Metrics (TTM)
Gross Margin
10.83%
Operating Margin
3.53%
Net Income Margin
2.02%
Return on Equity
7.64%
Return on Capital
7.93%
Return on Assets
2.47%
Earnings Yield
14.97%
Dividend Yield
3.91%
Payout Ratio
52.81%
Stock Overview
Market Cap
$1.35B
Shares Outstanding
183.81M
Volume
1
Avg. Volume
130.419
Financials (TTM)
Gross Profit
CN¥31.21B
Operating Income
CN¥10.17B
EBITDA
CN¥9.88B
Operating Cash Flow
CN¥7.53B
Capital Expenditure
-CN¥2.28B
Free Cash Flow
CN¥5.25B
Cash & ST Invst.
CN¥41.12B
Total Debt
CN¥51.42B
Shanghai Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥75.26B
+6.4%
Gross Profit
CN¥8.09B
+11.5%
Gross Margin
10.75%
N/A
Market Cap
$1.35B
N/A
Market Cap/Employee
$27.31K
N/A
Employees
49,402
N/A
Net Income
CN¥1.42B
+6.4%
EBITDA
CN¥2.77B
-7.1%
Quarterly Fundamentals
Total Cash
CN¥41.12B
-8.7%
Total Debt
CN¥51.42B
+0.8%
Accounts Receivable
CN¥96.78B
+6.0%
Inventory
CN¥41.68B
+10.2%
Long Term Debt
CN¥4.72B
-41.6%
Short Term Debt
CN¥46.70B
+8.8%
Return on Assets
2.47%
N/A
Return on Invested Capital
10.29%
N/A
Free Cash Flow
-CN¥1.70B
+42.2%
Operating Cash Flow
-CN¥1.01B
+54.2%